logo
搜索
菜单

视频 在线看

当前187/1397页
排序: 本月浏览数
14.19: Longitudinal Studies 01:26 min
14.19: Longitudinal Studies
3.2: Titration of a Strong Acid with a Strong Base 01:23 min
3.2: Titration of a Strong Acid with a Strong Base
3.1: Acid–Base Titration: Overview 01:26 min
3.1: Acid–Base Titration: Overview
1.22: What is ANOVA? 01:13 min
1.22: What is ANOVA?
25.16: Hypoglycemia and Glucagon 01:15 min
25.16: Hypoglycemia and Glucagon
25.15: Dipeptidyl Peptidase 4 Inhibitors 01:23 min
25.15: Dipeptidyl Peptidase 4 Inhibitors
25.14: Glucagon-like Receptor Agonists 01:24 min
25.14: Glucagon-like Receptor Agonists
25.13: Oral Hypoglycemic Agents: α-Glucosidase Inhibitors 01:19 min
25.13: Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
25.11: Oral Hypoglycemic Agents: Biguanides and Glitazones 01:26 min
25.11: Oral Hypoglycemic Agents: Biguanides and Glitazones
25.10: Oral Hypoglycemic Agents: Sulfonylureas 01:17 min
25.10: Oral Hypoglycemic Agents: Sulfonylureas
25.8: Insulin Formulations: Types and Delivery 01:27 min
25.8: Insulin Formulations: Types and Delivery
25.3: Insulin: The Receptor and Signaling Pathways 01:28 min
25.3: Insulin: The Receptor and Signaling Pathways
17.3: Drug Toxicity: Dose-Dependent Reactions 01:24 min
17.3: Drug Toxicity: Dose-Dependent Reactions
16.14: Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices 01:28 min
16.14: Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components 01:14 min
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect 01:28 min
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
14.9: Pharmacogenomics: Identification of New Drug Targets 01:29 min
14.9: Pharmacogenomics: Identification of New Drug Targets
14.7: Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters 01:16 min
14.7: Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
14.5: Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes 01:28 min
14.5: Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant 01:25 min
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
返回顶部